AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32950597 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified surveillance strategy for individuals with medium (6-10 mm) and large (>10 mm) nondysplastic LULs
Number of subjects: 1058
Study 32756135 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock-wave therapy (ESWT) - 3 sessions on the first, 14th, and 28th days
Number of subjects: 0
Study 32756135 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisolone - 30 mg daily for 2 weeks, then 15 mg daily for another 2 weeks
Number of subjects: 0
Study 35604613 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral erector spinae plane block using 20 ml of 0.375% ropivacaine on each side (ESPB group, n = 42)
Number of subjects: 84
Study 35604613 — intervention group
Group type: COMPARATOR
Intervention: No block (control group, n = 42)
Number of subjects: 84
Study 35604613 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral erector spinae plane block
Number of subjects: 84
Study 32331018 — intervention group
Group type: EXPERIMENTAL
Intervention: Valbenazine 40 mg
Number of subjects: 143
Study 32331018 — intervention group
Group type: EXPERIMENTAL
Intervention: Valbenazine 80 mg
Number of subjects: 143
Study 32331018 — intervention group
Group type: EXPERIMENTAL
Intervention: Valbenazine (40 or 80 mg)
Number of subjects: 143
Study 35296478 — intervention group
Group type: EXPERIMENTAL
Intervention: I-WOTCH intervention (multicomponent self-management support package)
Number of subjects: 0
Study 35296478 — intervention group
Group type: EXPERIMENTAL
Intervention: I-WOTCH intervention
Number of subjects: 0
Study 34320575 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical mandibular advancement (Group SG)
Number of subjects: 46
Study 34320575 — intervention group
Group type: COMPARATOR
Intervention: Premolar extractions (Group CG)
Number of subjects: 46
Study 34320575 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 46
Study 34148136 — intervention group
Group type: EXPERIMENTAL
Intervention: CFs‐SVM classifier integrating collagen area, straightness, and crosslink density
Number of subjects: 428
Study 34148136 — intervention group
Group type: EXPERIMENTAL
Intervention: CFs nomogram integrating CFs‐SVM classifier and clinicopathological characteristics
Number of subjects: 428
Study 34148136 — intervention group
Group type: COMPARATOR
Intervention: Traditional clinicopathological model
Number of subjects: 428
Study 33747831 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital educational support group administered through WhatsApp Messenger
Number of subjects: 58
Study 33768777 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping of the knee
Number of subjects: 31
Study 33768777 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Kinesio taping)
Number of subjects: 31
Study 33201347 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 400 mg daily for 8 days
Number of subjects: 17
Study 33201347 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 33533164 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck-specific exercises
Number of subjects: 144
Study 33533164 — intervention group
Group type: COMPARATOR
Intervention: General exercises
Number of subjects: 144
Study 33533164 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety at 3rd month
Number of subjects: 144
Study 33533164 — intervention group
Group type: EXPERIMENTAL
Intervention: Head pain at 3rd month
Number of subjects: 144
Study 33533164 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 144
Study 33533164 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck–arm pain
Number of subjects: 144
Study 35821379 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 29
Study 35821379 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Duration
Number of subjects: 29
Study 35821379 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Efficiency
Number of subjects: 29
Study 32830127 — intervention group
Group type: EXPERIMENTAL
Intervention: 360° incision
Number of subjects: 99
Study 32830127 — intervention group
Group type: EXPERIMENTAL
Intervention: upper-180° incision
Number of subjects: 99
Study 32830127 — intervention group
Group type: EXPERIMENTAL
Intervention: lower-180° incision
Number of subjects: 99
Study 35218405 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mg BUP (BUP16)
Number of subjects: 302
Study 34762980 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) for 4 weeks
Number of subjects: 70
Study 34762980 — intervention group
Group type: COMPARATOR
Intervention: Sham group (SG)
Number of subjects: 70
Study 33232628 — intervention group
Group type: COMPARATOR
Intervention: Group A: no planned follow-up contact
Number of subjects: 487
Study 33232628 — intervention group
Group type: COMPARATOR
Intervention: Group B: a single, planned, structured follow-up telephone contact with the research nurse the day after discharge
Number of subjects: 487
Study 33232628 — intervention group
Group type: COMPARATOR
Intervention: Group C: planned, structured follow-up telephone contact with the research nurse the day after discharge and then once weekly for 6 weeks
Number of subjects: 487
Study 33232628 — intervention group
Group type: COMPARATOR
Intervention: Group D: as Group C, but with planned, structured, coaching telephone contact
Number of subjects: 487
Study 32066625 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedDiet) intervention for 12 months
Number of subjects: 612
Study 33271458 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin composites (six different classifications and viscosities)
Number of subjects: 76
Study 32611505 — intervention group
Group type: EXPERIMENTAL
Intervention: Afatinib (30 mg or 40 mg orally daily)
Number of subjects: 106
Study 32611505 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (pemetrexed 500 mg/m2 + cisplatin 75 mg/m2 or carboplatin AUC 5 or 6 every 3 weeks × 4 cycles, followed by pemetrexed 500 mg/m2 every 3 weeks)
Number of subjects: 106
Study 35090173 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 h Nap schedule (6.5 h nocturnal sleep with a 90‐minute daytime nap)
Number of subjects: 53
Study 35090173 — intervention group
Group type: COMPARATOR
Intervention: 8 h No‐Nap, nocturnal‐only sleep schedule
Number of subjects: 53
Study 33258136 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading group
Number of subjects: 158
Study 33258136 — intervention group
Group type: COMPARATOR
Intervention: Delayed loading group
Number of subjects: 158
Study 35410927 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training with anodal tDCS
Number of subjects: 0
Study 35410927 — intervention group
Group type: COMPARATOR
Intervention: Cognitive training with sham tDCS
Number of subjects: 0
Study 35410927 — intervention group
Group type: COMPARATOR
Intervention: Defined muscle relaxation training with sham tDCS
Number of subjects: 0
Study 33530006 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus a brief educational video on safe storage and disposal practices of unused opioid pills
Number of subjects: 40
Study 33530006 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 40
Study 32937035 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised participant tracking system and retraining of sites regarding study procedures
Number of subjects: 997
Study 32937035 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive audit of enrollment forms
Number of subjects: 997
Study 35897080 — intervention group
Group type: EXPERIMENTAL
Intervention: Social incentives with gamification to promote exercise
Number of subjects: 220
Study 35897080 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injections
Number of subjects: 220
Study 35897080 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine-only injection
Number of subjects: 220
Study 35897080 — intervention group
Group type: COMPARATOR
Intervention: Fitbit without incentives
Number of subjects: 220
Study 34353223 — intervention group
Group type: EXPERIMENTAL
Intervention: Premenopausal women with menstruation related asthma worsening (PMA)
Number of subjects: 622
Study 34353223 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with irregular menstruation
Number of subjects: 622
Study 34353223 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri/postmenopausal women with menopausal hormone therapy (MHT)
Number of subjects: 622
Study 34353223 — intervention group
Group type: COMPARATOR
Intervention: Women without PMA
Number of subjects: 622
Study 34353223 — intervention group
Group type: COMPARATOR
Intervention: Women without MHT
Number of subjects: 622
Study 35148213 — intervention group
Group type: EXPERIMENTAL
Intervention: Inverted small flap (SF < 2 disc diameters)
Number of subjects: 25
Study 35148213 — intervention group
Group type: EXPERIMENTAL
Intervention: Inverted large flap (LF from 2 to 4 disc diameters)
Number of subjects: 25
Study 34101308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 8398
Study 34101308 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 8398
Study 32600149 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 64
Study 32600149 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 64
Study 35505432 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam followed by dexmedetomidine (group M-D)
Number of subjects: 252
Study 35505432 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam followed by propofol (group M-P)
Number of subjects: 252
Study 35505432 — intervention group
Group type: COMPARATOR
Intervention: Midazolam alone (group M)
Number of subjects: 252
Study 33503496 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month physical activity intervention (Exercise Group)
Number of subjects: 250
Study 33503496 — intervention group
Group type: COMPARATOR
Intervention: Health & Wellness Group (attention-comparison condition)
Number of subjects: 250
Study 35080109 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125 mg/kg IV pimobendan
Number of subjects: 6
Study 35080109 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg IV pimobendan
Number of subjects: 6
Study 35080109 — intervention group
Group type: EXPERIMENTAL
Intervention: IV pimobendan (both doses)
Number of subjects: 6
Study 35080109 — intervention group
Group type: EXPERIMENTAL
Intervention: IV pimobendan
Number of subjects: 6
Study 32390550 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment in patients with prior OAC
Number of subjects: 3162
Study 32390550 — intervention group
Group type: COMPARATOR
Intervention: Endovascular treatment in patients without prior OAC
Number of subjects: 3162
Study 33175117 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure BFR and resistance training (LP-RT)
Number of subjects: 24
Study 33175117 — intervention group
Group type: EXPERIMENTAL
Intervention: High-pressure BFR and resistance training (HP-RT)
Number of subjects: 24
Study 33175117 — intervention group
Group type: COMPARATOR
Intervention: Resistance training (RT)
Number of subjects: 24
Study 35588354 — intervention group
Group type: EXPERIMENTAL
Intervention: Active scapular correction
Number of subjects: 28
Study 35588354 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study 33417146 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg once daily for 4 weeks (Group A; n = 32)
Number of subjects: 66
Study 33417146 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 4 weeks (Group B; n = 34)
Number of subjects: 66
Study 32730852 — intervention group
Group type: EXPERIMENTAL
Intervention: Prespecified statistical analysis approach available
Number of subjects: 100
Study 32730852 — intervention group
Group type: EXPERIMENTAL
Intervention: Prespecified statistical analysis approach discrepancies
Number of subjects: 100
Study 32730852 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistician blinding until SAP signed off
Number of subjects: 100
Study 32730852 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistician blinding until database locked
Number of subjects: 100
Study 36404386 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril-valsartan
Number of subjects: 8399
Study 36404386 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 8399
Study 32075818 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-measuring contact lens (PMCL) device
Number of subjects: 8
Study 32075818 — intervention group
Group type: COMPARATOR
Intervention: Dynamic contour tonometry (DCT)
Number of subjects: 8
Study 33751206 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Decision Aids (PDAs)
Number of subjects: 3
Study 33026938 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg every 3 weeks for up to 2 years
Number of subjects: 628
Study 33026938 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (investigator's choice of paclitaxel, docetaxel, or irinotecan)
Number of subjects: 628
Study 33026938 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 628
Study 33026938 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 628
Study 33621314 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyrax expander
Number of subjects: 39
Study 33621314 — intervention group
Group type: COMPARATOR
Intervention: Haas expander
Number of subjects: 39
Study 33621314 — intervention group
Group type: EXPERIMENTAL
Intervention: Both expanders
Number of subjects: 39
Study 32584893 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital device providing real-time visualized brushing instructions
Number of subjects: 112
Study 32584893 — intervention group
Group type: COMPARATOR
Intervention: Control group using a digital device that only collected brushing logs
Number of subjects: 112
Study 35597518 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar anodal tDCS
Number of subjects: 20
Study 35597518 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 20
Study 34776157 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific cervical manipulation at the C6-7 segment (SCM)
Number of subjects: 21
Study 34776157 — intervention group
Group type: COMPARATOR
Intervention: Non-specific cervical manipulation (NSCM)
Number of subjects: 21
Study 35393715 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated intervention combining cognitive-behavioural stress management (CBSM) and progressive muscle relaxation (PMRs)
Number of subjects: 30
Study 35393715 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study 32662699 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet intervention with brief email guidance from a health educator (at least four structured emails during the first two weeks)
Number of subjects: 238
Study 32662699 — intervention group
Group type: COMPARATOR
Intervention: Internet intervention without brief email guidance
Number of subjects: 238
Study 36473425 — intervention group
Group type: EXPERIMENTAL
Intervention: ARA 100 mg/kg and DHA 50 mg/kg
Number of subjects: 120
Study 36473425 — intervention group
Group type: COMPARATOR
Intervention: Medium chain triglycerides (MCT) oil
Number of subjects: 120
Study 33241958 — intervention group
Group type: EXPERIMENTAL
Intervention: STHT (3-week strength-oriented training followed by 5-week hypertrophy-oriented training)
Number of subjects: 26
Study 33241958 — intervention group
Group type: COMPARATOR
Intervention: HT (8-week hypertrophy-oriented training)
Number of subjects: 26
Study 32785940 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy (single agents and combinations)
Number of subjects: 153
Study 32785940 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy
Number of subjects: 153
Study 32785940 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy
Number of subjects: 153
Study 36145087 — intervention group
Group type: EXPERIMENTAL
Intervention: Wagyu‐Cross beef (120 g consumed four days/week for four weeks)
Number of subjects: 0
Study 36145087 — intervention group
Group type: COMPARATOR
Intervention: Commercial beef (120 g consumed four days/week for four weeks)
Number of subjects: 0
Study 36145087 — intervention group
Group type: EXPERIMENTAL
Intervention: Wagyu‐Cross beef
Number of subjects: 0
Study 36145087 — intervention group
Group type: COMPARATOR
Intervention: Commercial beef
Number of subjects: 0
Study 35429946 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (20 mg/kg initial dose, then 10 mg/kg daily maintenance)
Number of subjects: 90
Study 35429946 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 90
Study 35429946 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 90
Study 35429946 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study 33165219 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention (6 × 20-minute sessions of focused-attention mindfulness)
Number of subjects: 93
Study 33165219 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham mindfulness intervention
Number of subjects: 93
Study 33165219 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 93
Study 33165219 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 93
Study 35183551 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-assisted group (n = 295)
Number of subjects: 576
Study 35183551 — intervention group
Group type: COMPARATOR
Intervention: Unaided group (n = 281)
Number of subjects: 576
Study 35183551 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondermatology trainees (AI-assisted, n = 150)
Number of subjects: 576
Study 35183551 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermatology residents (AI-assisted)
Number of subjects: 576
Study 35183551 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-assisted group (trainees)
Number of subjects: 576
Study 34814657 — intervention group
Group type: EXPERIMENTAL
Intervention: Mud plus bath therapy (group 1)
Number of subjects: 89
Study 32891286 — intervention group
Group type: EXPERIMENTAL
Intervention: Cupping therapy at -0.02 mpa
Number of subjects: 91
Study 32891286 — intervention group
Group type: EXPERIMENTAL
Intervention: Cupping therapy at -0.03 mpa
Number of subjects: 91
Study 32891286 — intervention group
Group type: EXPERIMENTAL
Intervention: Cupping therapy at -0.05 mpa
Number of subjects: 91
Study 32161005 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-VEGF therapy
Number of subjects: 54
Study 35124808 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative high-dose dexamethasone (1 mg/kg)
Number of subjects: 120
Study 35124808 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 120
Study 34330595 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 300 mg once daily
Number of subjects: 40
Study 34330595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 35523502 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CT scan (LDCT)
Number of subjects: 495
Study 35523502 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasonography (LUS)
Number of subjects: 495
Study 35523502 — intervention group
Group type: COMPARATOR
Intervention: Chest X-ray (CXR)
Number of subjects: 495
Study 34852814 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program based on Theory of Planned Behavior (TPB)
Number of subjects: 150
Study 34852814 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 150
Study 34934009 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP + pressure support ventilation (PSV)
Number of subjects: 35
Study 34934009 — intervention group
Group type: COMPARATOR
Intervention: Pressure control (PC)/intermittent mandatory ventilation (IMV) + PSV
Number of subjects: 35
Study 34934009 — intervention group
Group type: EXPERIMENTAL
Intervention: Downward titration of the level of pressure support (PSV)
Number of subjects: 35
Study 32088668 — intervention group
Group type: EXPERIMENTAL
Intervention: Live harp music
Number of subjects: 46
Study 32088668 — intervention group
Group type: COMPARATOR
Intervention: Recorded harp music
Number of subjects: 46
Study 34197338 — intervention group
Group type: EXPERIMENTAL
Intervention: Dog-Assisted Therapy (DAT)
Number of subjects: 21
Study 34197338 — intervention group
Group type: COMPARATOR
Intervention: Control group (no DAT)
Number of subjects: 21
Study 33469944 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate increasing trajectory from age 10 to 18
Number of subjects: 704
Study 33469944 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-to-moderate increasing trajectory across childhood
Number of subjects: 704
Study 33469944 — intervention group
Group type: COMPARATOR
Intervention: Very low decreasing group (baseline)
Number of subjects: 704
Study 32100168 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual care based on the sound heart model
Number of subjects: 92
Study 32100168 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing interventions (Control)
Number of subjects: 92
Study 36456715 — intervention group
Group type: EXPERIMENTAL
Intervention: Lespedeza cuneata extract gargle
Number of subjects: 82
Study 36456715 — intervention group
Group type: COMPARATOR
Intervention: Saline gargle
Number of subjects: 82
Study 34298029 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline 200 mg with Oxycodone 40 mg
Number of subjects: 12
Study 34298029 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline 100 mg with Oxycodone 40 mg
Number of subjects: 12
Study 34298029 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone 40 mg alone
Number of subjects: 12
Study 33306927 — intervention group
Group type: EXPERIMENTAL
Intervention: Motion-control shoes
Number of subjects: 372
Study 33306927 — intervention group
Group type: COMPARATOR
Intervention: Standard neutral shoes
Number of subjects: 372
Study 32696964 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong with Sam (SmS) program
Number of subjects: 92
Study 32696964 — intervention group
Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 92
Study 33743615 — intervention group
Group type: EXPERIMENTAL
Intervention: T1-2WI radiomic model using multivariable logistic regression (MLR)
Number of subjects: 252
Study 33743615 — intervention group
Group type: COMPARATOR
Intervention: Clinical model
Number of subjects: 252
Study 32474633 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning algorithm based on 3D ResNet architecture
Number of subjects: 694